PreprintAll rights reservedbioRxiv2 Sep 2026

Synergistic targeting of EP300/CBP and EYA co-activators collapses the rhabdomyosarcoma core regulatory circuit

A. L. Gustafson
S. Nance
B. Gryder
N. A. M. Shendy
L. Wick
G. McKay-Corkum
K. E. Ritter
S. C. Purdy
A. R. Wolin
S. R. Rosenbaum
S. Mathavarajah
N. A. Demelfi

24 more authors

Y. Wang
Y. Zhang
M. Zimmerman
A. Kavirayani
E. A. Citarella
V. J. Ebegboni
J. W. Hardin
A. LaVeck
X. Wang
N. Dharia
A. L. Hong
G. Kugener
J. S. Boehm
J. A. Roth
J. Khan
F. Vazquez
K. Artinger
R. Zhao
D. M. Langenau
J. Qi
K. Stegmaier
B. Abraham
H. Ford
A. D. Durbin¹

¹St. Jude Children's Research Hospital

Read full text PDF DOI Cite

Synergistic nanotheranostic platform for fluorescence/magnetic resonance bimodal imaging-guided near infrared photoimmuno-chemodynamic thermal targeting therapy.
Kohei Matsuoka, Mizuki Yamada, Ryu Okada +12
Journal of nanobiotechnology14 Oct 2026Peer-reviewedCC BY-NC-NDFull textSystems & synthetic biology General medicineEurope PMCDOAJ
NLRP3 inflammasome-driven inflammation as a cause of atrial fibrillation: potential synergistic inhibition of the NLRP3 via upstream magnesium repletion and targeting NLRP3 with a downstream inhibitor
Alan Wanderer
Frontiers in Cardiovascular Medicine4 Nov 2026Peer-reviewedCC BY 4.0Cardiovascular medicineCrossref
Targeting regulatory T cells in gastrointestinal cancers: current status and future perspectives
Koichi Jinushi, Takuro Saito, Yuichiro Doki
International Journal of Clinical Oncology11 May 2026Peer-reviewedCC BY 4.0Full textOncologyPMC
Epigenetic targeting of an HBO1-H3K9la-CHI3L1 axis reduces regulatory B cell-mediated CD8+ T cell dysfunction in lung adenocarcinoma
Xuyu Gu, Junjie Zhu, Tao Ge +4
Journal for Immunotherapy of Cancer30 Oct 2026Peer-reviewedCC BY-NC 4.0Full textOncologyPMC
Thromboelastographic Assessment of the Differential Sensitivity of Three Contact Activators to Coagulation Factor Deficiencies in Hemocell Environments
Weiguo Liang, Mao Xia, Junpo Li +3
Diagnostics (Basel, Switzerland)1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeX RIS

BibTeX

@misc{gustafson2026synergistic,
  title = {{Synergistic targeting of EP300/CBP and EYA co-activators collapses the rhabdomyosarcoma core regulatory circuit}},
  author = {A. L. Gustafson and S. Nance and B. Gryder and N. A. M. Shendy and L. Wick and G. McKay-Corkum and K. E. Ritter and S. C. Purdy and A. R. Wolin and S. R. Rosenbaum and S. Mathavarajah and N. A. Demelfi and Y. Wang and Y. Zhang and M. Zimmerman and A. Kavirayani and E. A. Citarella and V. J. Ebegboni and J. W. Hardin and A. LaVeck and X. Wang and N. Dharia and A. L. Hong and G. Kugener and J. S. Boehm and J. A. Roth and J. Khan and F. Vazquez and K. Artinger and R. Zhao and D. M. Langenau and J. Qi and K. Stegmaier and B. Abraham and H. Ford and A. D. Durbin},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.02.748955},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.02.748955v1},
}

RIS

TY  - UNPB
TI  - Synergistic targeting of EP300/CBP and EYA co-activators collapses the rhabdomyosarcoma core regulatory circuit
AU  - A. L. Gustafson
AU  - S. Nance
AU  - B. Gryder
AU  - N. A. M. Shendy
AU  - L. Wick
AU  - G. McKay-Corkum
AU  - K. E. Ritter
AU  - S. C. Purdy
AU  - A. R. Wolin
AU  - S. R. Rosenbaum
AU  - S. Mathavarajah
AU  - N. A. Demelfi
AU  - Y. Wang
AU  - Y. Zhang
AU  - M. Zimmerman
AU  - A. Kavirayani
AU  - E. A. Citarella
AU  - V. J. Ebegboni
AU  - J. W. Hardin
AU  - A. LaVeck
AU  - X. Wang
AU  - N. Dharia
AU  - A. L. Hong
AU  - G. Kugener
AU  - J. S. Boehm
AU  - J. A. Roth
AU  - J. Khan
AU  - F. Vazquez
AU  - K. Artinger
AU  - R. Zhao
AU  - D. M. Langenau
AU  - J. Qi
AU  - K. Stegmaier
AU  - B. Abraham
AU  - H. Ford
AU  - A. D. Durbin
PY  - 2026
DA  - 2026/09/02
PB  - bioRxiv
DO  - 10.64898/2026.09.02.748955
UR  - https://www.biorxiv.org/content/10.64898/2026.09.02.748955v1
ER  -

Related

Cite